SKK
ABBV icon

Shepherd Kaplan Krochuk’s AbbVie ABBV Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,500
Closed -$710K – 223
2018
Q1 		$710K Buy
+7,500
New +$824K 0.43% 68

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Shepherd Kaplan Krochuk's ABBV Position: Q1 2026 in Review

Shepherd Kaplan Krochuk reduced its AbbVie (ABBV) stake by 0.31% in Q1 2026, selling an estimated $1.33K and leaving 1,910 shares worth $415K. The position accounts for 0.35% of the portfolio, ranked #50.

Shepherd Kaplan Krochuk first reported a position in ABBV in Q2 2020 and has held it in 13 quarters since. The position peaked at $1.14M in Q4 2021. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Shepherd Kaplan Krochuk held 1,910 shares of AbbVie worth $415K as of Q1 2026.
  • Shepherd Kaplan Krochuk sold 6 AbbVie shares in Q1 2026, an estimated $1.33K.
  • AbbVie made up 0.35% of Shepherd Kaplan Krochuk's portfolio in Q1 2026, its #50 holding.
  • Shepherd Kaplan Krochuk first reported a position in AbbVie in Q2 2020 and has held it in 13 quarters since.
  • Shepherd Kaplan Krochuk's AbbVie position peaked at $1.14M in Q4 2021.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2026, filed 15 May 2026.